{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:16:22Z","timestamp":1771424182965,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04200-1","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:28:54Z","timestamp":1769513334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR-4326 predicts adverse outcomes of triple-negative breast cancer and regulates cell growth and motility through modulating MED13"],"prefix":"10.1186","volume":"24","author":[{"given":"Weina","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linna","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huihui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"4200_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s10916-020-01581-y","volume":"44","author":"A Hakim","year":"2020","unstructured":"Hakim A, Awale RN. Thermal Imaging - An emerging modality for breast cancer detection: A comprehensive review. J Med Syst. 2020;44:136.","journal-title":"J Med Syst"},{"key":"4200_CR2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1634\/theoncologist.2017-0535","volume":"23","author":"JJ Gao","year":"2018","unstructured":"Gao JJ, Swain SM. Luminal A breast cancer and molecular assays: A review. Oncologist. 2018;23:556\u201365.","journal-title":"Oncologist"},{"key":"4200_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1158\/1055-9965.EPI-17-0627","volume":"27","author":"N Howlader","year":"2018","unstructured":"Howlader N, Cronin KA, Kurian AW, Andridge R. Differences in breast cancer survival by molecular subtypes in the united States. Cancer Epidemiol Biomarkers Prev. 2018;27:619\u201326.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4200_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","volume":"22","author":"L Yin","year":"2020","unstructured":"Yin L, Duan JJ, Bian XW, Yu SC. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 2020;22:61.","journal-title":"Breast Cancer Res"},{"key":"4200_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","volume":"15","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang H, Merkher Y, Chen L, Liu N, Leonov S, Chen Y. Recent advances in therapeutic strategies for triple-negative breast cancer. J Hematol Oncol. 2022;15:121.","journal-title":"J Hematol Oncol"},{"key":"4200_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/14737140.2021.1840984","volume":"21","author":"J Sukumar","year":"2021","unstructured":"Sukumar J, Gast K, Quiroga D, Lustberg M, Williams N. Triple-negative breast cancer: promising prognostic biomarkers currently in development. Expert Rev Anticancer Ther. 2021;21:135\u201348.","journal-title":"Expert Rev Anticancer Ther"},{"key":"4200_CR7","doi-asserted-by":"publisher","first-page":"e0157368","DOI":"10.1371\/journal.pone.0157368","volume":"11","author":"BD Lehmann","year":"2016","unstructured":"Lehmann BD, Jovanovi\u0107 B, Chen X, Estrada MV, Johnson KN, Shyr Y, Moses HL, Sanders ME, Pietenpol JA. Refinement of Triple-Negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection. PLoS ONE. 2016;11:e0157368.","journal-title":"PLoS ONE"},{"key":"4200_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/PPO.0000000000000498","volume":"27","author":"A Marra","year":"2021","unstructured":"Marra A, Curigliano G. Adjuvant and neoadjuvant treatment of Triple-Negative breast cancer with chemotherapy. Cancer J. 2021;27:41\u20139.","journal-title":"Cancer J"},{"key":"4200_CR9","doi-asserted-by":"publisher","first-page":"2735251","DOI":"10.1155\/2022\/2735251","volume":"2022","author":"J Xu","year":"2022","unstructured":"Xu J, Cen X, Yao Y, Zhao S, Li W, Zhang W, Qiu M. Identification of six N7-Methylguanosine-Related MiRNA signatures to predict the overall survival and immune landscape of Triple-Negative breast cancer through in Silico analysis. J Oncol. 2022;2022:2735251.","journal-title":"J Oncol"},{"key":"4200_CR10","doi-asserted-by":"crossref","unstructured":"Kurozumi S, Seki N, Narusawa E, Honda C, Tokuda S, Nakazawa Y, Yokobori T, Katayama A, Mongan NP, Rakha EA, et al. Identification of MicroRNAs associated with histological grade in Early-Stage invasive breast cancer. Int J Mol Sci. 2023;25:35\u201345.","DOI":"10.3390\/ijms25010035"},{"key":"4200_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11010-017-3219-2","volume":"443","author":"G Xu","year":"2018","unstructured":"Xu G, Zhang Z, Zhang L, Chen Y, Li N, Lv Y, Li Y, Xu X. miR-4326 promotes lung cancer cell proliferation through targeting tumor suppressor APC2. Mol Cell Biochem. 2018;443:151\u20137.","journal-title":"Mol Cell Biochem"},{"key":"4200_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12885-024-13392-2","volume":"25","author":"H Deli","year":"2025","unstructured":"Deli H, Vakili-Ghartavol Z, Asgari Y, Tavoosidana G, Eftekhar E, Ghahremani MH. The expression of Exosomal and cellular MiRNAs in predicting oxaliplatin resistance in colorectal cancer cells: an in Silico and in vitro study. BMC Cancer. 2025;25:46.","journal-title":"BMC Cancer"},{"key":"4200_CR13","first-page":"4001","volume":"16","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Luan Y, Chang H, Chen G. The diagnostic and prognostic value of plasma microRNA-125b-5p in patients with multiple myeloma. Oncol Lett. 2018;16:4001\u20137.","journal-title":"Oncol Lett"},{"key":"4200_CR14","doi-asserted-by":"publisher","first-page":"111852","DOI":"10.1016\/j.celrep.2022.111852","volume":"41","author":"M Ren","year":"2022","unstructured":"Ren M, Yang Y, Heng KHY, Ng LY, Chong CY, Ng YT, Gorur-Shandilya S, Lee RMQ, Lim KL, Zhang J, Koh TW. MED13 and Glycolysis are conserved modifiers of \u03b1-synuclein-associated neurodegeneration. Cell Rep. 2022;41:111852.","journal-title":"Cell Rep"},{"key":"4200_CR15","first-page":"e59904","volume":"16","author":"MD Rivera","year":"2024","unstructured":"Rivera MD, Aponte SN, Rivera F, Arciniegas NJ, Carlo S. MED13 gene mutation related to autism spectrum disorder: A case report. Cureus. 2024;16:e59904.","journal-title":"Cureus"},{"key":"4200_CR16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00439-018-1887-y","volume":"137","author":"L Snijders Blok","year":"2018","unstructured":"Snijders Blok L, Hiatt SM, Bowling KM, Prokop JW, Engel KL, Cochran JN, Bebin EM, Bijlsma EK, Ruivenkamp CAL, Terhal P, et al. De Novo mutations in MED13, a component of the mediator complex, are associated with a novel neurodevelopmental disorder. Hum Genet. 2018;137:375\u201388.","journal-title":"Hum Genet"},{"key":"4200_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.seizure.2022.09.002","volume":"101","author":"M Trivisano","year":"2022","unstructured":"Trivisano M, De Dominicis A, Micalizzi A, Ferretti A, Dentici ML, Terracciano A, Calabrese C, Vigevano F, Novelli G, Novelli A, Specchio N. MED13 mutation: A novel cause of developmental and epileptic encephalopathy with infantile spasms. Seizure. 2022;101:211\u20137.","journal-title":"Seizure"},{"key":"4200_CR18","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s12253-016-0070-9","volume":"22","author":"YS Jo","year":"2016","unstructured":"Jo YS, Choi MR, Song SY, Kim MS, Yoo NJ, Lee SH. Frameshift mutations of HSPA4 and MED13 in gastric and colorectal cancers. Pathol Oncol Res. 2016;22:769\u201372.","journal-title":"Pathol Oncol Res"},{"key":"4200_CR19","doi-asserted-by":"publisher","first-page":"e34474","DOI":"10.1016\/j.heliyon.2024.e34474","volume":"10","author":"G Han","year":"2024","unstructured":"Han G, Wang X, Pu K, Li Z, Li Q, Tong X. Identification of a prognosis-related phagocytosis regulator gene signature in Medulloblastoma. Heliyon. 2024;10:e34474.","journal-title":"Heliyon"},{"key":"4200_CR20","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2174\/156800961508151001105814","volume":"15","author":"EV Broude","year":"2015","unstructured":"Broude EV, Gyorffy B, Chumanevich AA, Chen M, McDermott MS, Shtutman M, Catroppo JF, Roninson IB. Expression of CDK8 and CDK8-interacting genes as potential biomarkers in breast cancer. Curr Cancer Drug Targets. 2015;15:739\u201349.","journal-title":"Curr Cancer Drug Targets"},{"key":"4200_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1186\/s12935-020-01651-8","volume":"20","author":"L Xing","year":"2020","unstructured":"Xing L, Xia M, Jiao X, Fan L. Hsa_circ_0004831 serves as a blood-based prognostic biomarker for colorectal cancer and its potentially circRNA-miRNA-mRNA regulatory network construction. Cancer Cell Int. 2020;20:557.","journal-title":"Cancer Cell Int"},{"key":"4200_CR22","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.7150\/thno.11543","volume":"5","author":"G Bertoli","year":"2015","unstructured":"Bertoli G, Cava C, Castiglioni I. MicroRNAs: new biomarkers for Diagnosis, Prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics. 2015;5:1122\u201343.","journal-title":"Theranostics"},{"key":"4200_CR23","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.7150\/ijbs.47203","volume":"16","author":"B He","year":"2020","unstructured":"He B, Zhao Z, Cai Q, Zhang Y, Zhang P, Shi S, Xie H, Peng X, Yin W, Tao Y, Wang X. miRNA-based biomarkers, therapies, and resistance in cancer. Int J Biol Sci. 2020;16:2628\u201347.","journal-title":"Int J Biol Sci"},{"key":"4200_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12943-018-0897-7","volume":"17","author":"Z Sun","year":"2018","unstructured":"Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang G, Song J, Li Z, Zhang Z, Yuan W. Effect of Exosomal MiRNA on cancer biology and clinical applications. Mol Cancer. 2018;17:147.","journal-title":"Mol Cancer"},{"key":"4200_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00428-021-03128-z","volume":"480","author":"G Cserni","year":"2022","unstructured":"Cserni G, Maguire A, Bianchi S, Ryska A, Kovacs A. Sentinel lymph node assessment in breast cancer-an update on current recommendations. Virchows Arch. 2022;480:95\u2013107.","journal-title":"Virchows Arch"},{"key":"4200_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1615\/CritRevImmunol.2024055296","volume":"45","author":"Z Guo","year":"2025","unstructured":"Guo Z, Zhu H, Zhang R, Shan Q, Wang Y. miR-205-5p promotes the Proliferation, Migration, and invasion of nasopharyngeal carcinoma cells by regulating CALM1. Crit Rev Immunol. 2025;45:25\u201338.","journal-title":"Crit Rev Immunol"},{"key":"4200_CR27","doi-asserted-by":"crossref","unstructured":"Lara P, Aguilar-Gonz\u00e1lez A, Mart\u00edn F, Mesas C, Moreno J, Rama AR. Exploring miR-21 Knock-Out using CRISPR\/Cas as a treatment for lung cancer. Genes (Basel). 2025;16:133\u201348.","DOI":"10.3390\/genes16020133"},{"key":"4200_CR28","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.mjafi.2024.02.002","volume":"80","author":"P Misra","year":"2024","unstructured":"Misra P, Boruah RP, Gambhirrao D, Godse A, Mk R, Gupta S, Vashum A. The effects of miR-217 inhibitor and mimic in the progression of Kirsten rat sarcoma viral oncogene homologue driven cancers. Med J Armed Forces India. 2024;80:702\u201311.","journal-title":"Med J Armed Forces India"},{"key":"4200_CR29","doi-asserted-by":"crossref","unstructured":"Cupertino SES, Goncalves ACA, Gusmao Lopes CV, Gradia DF, Beltrame MH. The current state of breast cancer genetics in populations of African ancestry. Genes (Basel). 2025;16:199\u2013213.","DOI":"10.3390\/genes16020199"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04200-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04200-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04200-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:54:01Z","timestamp":1771422841000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04200-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4200"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04200-1","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The Ethics Committee of Zibo Central Hospital approved the study, and all enrolled patients provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}